Chris Flores, PhD

Chris Flores, PhD has extensive work experience in the field of research and development. Currently, they hold the position of President and Chief Research & Development Officer at Doloromics since 2021. Prior to this, they worked at Johnson & Johnson for a significant period. Their roles at Johnson & Johnson include Vice President, Neuroscience Therapeutic Area at Janssen R&D from 2018 to 2021, Head, Emerging Science and Innovation Strategy at Johnson & Johnson Consumer from 2015 to 2018, Global Head, External Innovation, Discovery Sciences at Janssen R&Dfrom 2013 to 2015, Senior Director, Pain Franchise Strategy Leader, Neuroscience Therapeutic Area at Janssen R&D from 2011 to 2013, Senior Director, External Innovation, Neuroscience Therapeutic Area at Janssen R&D from 2009 to 2011, and Head of Pain Discovery, Neuroscience Therapeutic Area at Janssen R&D from 2002 to 2009.

Before joining Johnson & Johnson, Chris Flores worked as an Associate Professor at The University of Texas Health Science Center at San Antonio from 1997 to 2002. Prior to this, they held the position of Assistant Professor at the University of Minnesota from 1994 to 1997. Their earlier experience includes working as a Staff Fellow at The National Institutes of Health, NINDS from 1992 to 1994 and as a Research Biologist at The National Institutes of Health, NIDR from 1985 to 1987.

Chris Flores, PhD has a Bachelor of Science degree in Physiology from the University of California, Davis. Chris also completed a PhD in Pharmacology from Georgetown University. Further educational details such as start and end years for each degree are not provided.